COMPARATIVE-EVALUATION OF MICROPLATE ENZYME-LINKED-IMMUNOSORBENT-ASSAY VERSUS PLAQUE REDUCTION ASSAY FOR ANTIVIRAL SUSCEPTIBILITY TESTING OF HERPES-SIMPLEX VIRUS ISOLATES
S. Safrin et al., COMPARATIVE-EVALUATION OF MICROPLATE ENZYME-LINKED-IMMUNOSORBENT-ASSAY VERSUS PLAQUE REDUCTION ASSAY FOR ANTIVIRAL SUSCEPTIBILITY TESTING OF HERPES-SIMPLEX VIRUS ISOLATES, Antimicrobial agents and chemotherapy, 40(4), 1996, pp. 1017-1019
We tested the antiviral susceptibilities of 30 clinical isolates of he
rpes simplex virus using the microplate in situ enzyme-linked immunoso
rbent assay (MISE) and the plaque reduction assay (PRA). There was con
cordance for 26 of 30 acyclovir results and all 30 foscarnet results.
MISE and PRA results each predicted the response to acyclovir in 12 of
14 instances and the response to foscarnet in 8 instances. MISE is mo
re rapid than PRA, has an objective endpoint, and correlates well with
the clinical response to therapy.